Literature DB >> 24063530

Gold(I)-phosphine-N-heterocycles: biological activity and specific (ligand) interactions on the C-terminal HIVNCp7 zinc finger.

Camilla Abbehausen1, Erica J Peterson, Raphael E F de Paiva, Pedro P Corbi, André L B Formiga, Yun Qu, Nicholas P Farrell.   

Abstract

The syntheses and the characterization by chemical analysis, (1)H and (31)P NMR spectroscopy, and mass spectrometry of a series of linear triphenylphosphine gold(I) complexes with substituted N-heterocycle ligands (L), [(PPh3)Au(I)(L)](+), is reported. The reaction of [(PPh3)Au(L)](+) (L = Cl(-) or substituted N- heterocyclic pyridine) with the C-terminal (Cys3His) finger of HIVNCp7 shows evidence by mass spectrometry (ESI-MS) and (31)P NMR spectroscopy of a long-lived {(PPh3)Au}-S-peptide species resulting from displacement of the chloride or pyridine ligand by zinc-bound cysteine with concomitant displacement of Zn(2+). In contrast, reactions with the Cys2His2 finger-3 of the Sp1 transcription factor shows significantly reduced intensities of {(PPh3)Au} adducts. The results suggest the possibility of systematic (electronic, steric) variations of "carrier" group PR3 and "leaving" group L as well as the nature of the zinc finger in modulation of biological activity. The cytotoxicity, cell cycle signaling effects, and cellular accumulation of the series are also reported. All compounds display cytotoxicity in the micromolar range upon 96 h continuous exposure to human tumor cells. The results may have relevance for the reported inhibition of viral load in simian virus by the gold(I) drug auranofin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24063530     DOI: 10.1021/ic401535s

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  8 in total

1.  Cu(I) Disrupts the Structure and Function of the Nonclassical Zinc Finger Protein Tristetraprolin (TTP).

Authors:  Geoffrey D Shimberg; Kiwon Ok; Heather M Neu; Kathryn E Splan; Sarah L J Michel
Journal:  Inorg Chem       Date:  2017-05-30       Impact factor: 5.165

2.  Synthesis, reactivity, and biological activity of gold(I) complexes modified with thiourea-functionalized tyrosine kinase inhibitors.

Authors:  Mu Yang; Amanda J Pickard; Xin Qiao; Matthew J Gueble; Cynthia S Day; Gregory L Kucera; Ulrich Bierbach
Journal:  Inorg Chem       Date:  2015-03-20       Impact factor: 5.165

3.  The Effect of Salts in Promoting Specific and Competitive Interactions between Zinc Finger Proteins and Metals.

Authors:  Gongyu Li; Siming Yuan; Shihui Zheng; Yuting Chen; Zhen Zheng; Yangzhong Liu; Guangming Huang
Journal:  J Am Soc Mass Spectrom       Date:  2017-09-08       Impact factor: 3.109

4.  Gold(I) complexes of 9-deazahypoxanthine as selective antitumor and anti-inflammatory agents.

Authors:  Ján Vančo; Jana Gáliková; Jan Hošek; Zdeněk Dvořák; Lenka Paráková; Zdeněk Trávníček
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

5.  In Vitro Antitumor Active Gold(I) Triphenylphosphane Complexes Containing 7-Azaindoles.

Authors:  Pavel Štarha; Zdeněk Trávníček; Bohuslav Drahoš; Zdeněk Dvořák
Journal:  Int J Mol Sci       Date:  2016-12-11       Impact factor: 5.923

6.  Gold(I/III)-Phosphine Complexes as Potent Antiproliferative Agents.

Authors:  Jong Hyun Kim; Evan Reeder; Sean Parkin; Samuel G Awuah
Journal:  Sci Rep       Date:  2019-08-26       Impact factor: 4.379

7.  Interaction of Natural Compounds in Licorice and Turmeric with HIV-NCp7 Zinc Finger Domain: Potential Relevance to the Mechanism of Antiviral Activity.

Authors:  Runjing Wang; Yinyu Wei; Meiqin Wang; Pan Yan; Hongliang Jiang; Zhifeng Du
Journal:  Molecules       Date:  2021-06-10       Impact factor: 4.411

8.  Gold(I)-triphenylphosphine complexes with hypoxanthine-derived ligands: in vitro evaluations of anticancer and anti-inflammatory activities.

Authors:  Radka Křikavová; Jan Hošek; Ján Vančo; Jakub Hutyra; Zdeněk Dvořák; Zdeněk Trávníček
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.